Contact information

Laura Diego, Policy Expert
Calle Josep Pla, 2
+34 934 85 94 00
Areas of activities
  • A. Health Biotechnology
    • Areas of activity
      • Biodrugs
      • Drug development
      • Drug discovery
      • Cellular Therapy
      • Gene Therapy
      • Transplant
      • Vaccines
    • Therapeutic areas
      • Analgesia & Pain
      • Dermatology
      • Musculoskeletal system
      • Cardiovascular diseases and circulatory system
      • Genetic and rare diseases
      • Infectious diseases
      • Inflammatory diseases
      • Immunology
      • Oncology
      • Blood and lymphatic system
      • Digestive system and hepatology
      • Kidney and genitourinary system
      • Central nervous system
      • Respiratory and pulmonary system
      • Metabolic disorders / Endocrinology
  • C. Industrial Biotechnology
    • APIs and green chemistry
    • Enzymes
    • Microorganism
    • Chemistry
  • D. Services
    • R&D services
      • Bioinformatics
    • Professional services
      • Consultancy
      • Training and spreading
      • Investment / Venture Capital
      • Sector dynamisation

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.



Products and services

Sanofi has 4 main areas:

  • Sanofi Genzyme, the specialty care unit, which includes:
    • Immunology, with special focus on dermatological, respiratory and chronic gastrointestinal diseases.
    • Oncology, focused on multiple tumours such as multiple myeloma, lymphoma, skin, lung, cervical or breast cancer, among others. 
    • Rare Diseases, focusing on lysosomal diseases such as Gaucher, Pompe, Fabry or MPSI. Currently also focused on rare blood disorders such as aTTP (acquired thrombotic thrombocytopenic purpura).
    • Multiple Sclerosis, with current and investigational treatments.
  • Sanofi Pasteur, with a portfolio of vaccines offering protection against a wide range of infectious diseases, from cholera, dengue and diphtheria to Haemophilus influenzae type b, polio, pertussis, tetanus, hepatitis A and B, meningitis or influenza. Also immersed in the fight against COVID.
  • General Medicines, where cardiovascular and diabetes diseases are key areas. Sanofi has been at the forefront of diabetes and cardiovascular management for almost a century. 
  • CHC, where the focus is on Allergy, Cough and Cold, Pain, Digestive and Nutritional Products.